C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/14 (2006.01) A61K 31/519 (2006.01) A61K 31/55 (2006.01) A61P 25/28 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2468649
Disclosed herein are compounds having the structural formula (A) including pharmaceutically acceptable salts or solvates of said compound, wherein X, Y, Q and R are as defined in the specification; pharmaceutical compositions thereof; methods of treating central nervous system diseases by administering the compound of the present invention to a patient in need of such treatment, and processes for preparing the compound of this invention.
L'invention concerne des composés de formule structurelle (A) comprenant des solvates ou des sels acceptables sur le plan pharmaceutique, dans ladite formule X, Y, Q et R étant définis tels que dans la revendication. Cette invention a également trait à des compositions pharmaceutiques associées, à des méthodes de traitement de maladies du système nerveux central par administration du composé de cette invention à un patient nécessitant un tel traitement, et à des procédés de préparation dudit composé.
Boyle Craig D.
Chackalamannil Samuel
Greenlee William J.
Shah Unmesh G.
Xia Yan
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Adenosine a2a receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine a2a receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a2a receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846741